Stories
Slash Boxes
Comments

SoylentNews is people

posted by janrinok on Thursday June 04 2015, @07:49PM   Printer-friendly
from the any-progress-is-good dept.

Patients with terminal cancer could "effectively be cured" by the discovery of a pair of drugs which can shrink tumours or bring them under control in nearly 60% of people with advanced melanoma.

In an international trial of 945 patients, treatment with the drugs ipilimumab and nivolumab stopped the cancer advancing for nearly a year in 58% of cases. This was compared with 19% of cases for ipilimumab alone, which resulted in tumours stabilising or shrinking for an average of two and a half months.

The treatment, known as immunotherapy, uses the body's immune system to attack cancerous cells. Researchers say it could replace chemotherapy as the standard treatment for cancer within five years.

[Paper]: http://www.nejm.org/doi/full/10.1056/NEJMoa1504030#t=article


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 0) by Anonymous Coward on Thursday June 04 2015, @11:48PM

    by Anonymous Coward on Thursday June 04 2015, @11:48PM (#192304)

    blockquote>
    In contrast to normal cells, aneuploidy--alterations in the number of chromosomes--is consistently observed in virtually all cancers. A growing body of evidence suggests that aneuploidy is often caused by a particular type of genetic instability, called chromosomal instability, which may reflect defects in mitotic segregation in cancer cells. A better understanding of the molecular mechanisms leading to aneuploidy holds promise for the development of cancer drugs that target this process.

    http://www.ncbi.nlm.nih.gov/pubmed/15549096 [nih.gov]

    It's one disease, they just don't teach about aneuploidy and cancer in med/grad school much (I don't remember a single mention). We need a way of detecting and targeting cells with the wrong number of chromosomes. Simple as that, in concept at least.

  • (Score: 3, Informative) by Joe on Friday June 05 2015, @12:45AM

    by Joe (2583) on Friday June 05 2015, @12:45AM (#192318)

    It's one disease

    I disagree, but it really is just semantics. I would say that it is a class or type of diseases (autoimmunity, neurodegenerative, infectious, metabolic, poisoning, etc.) as it has many commonalities, but different types of cancer are divergent enough to need distinct treatment programs (you can't cut-out a leukemia and you can't cure a glioblastoma with a bone marrow transplant).

    Genomic instability is one of the hallmarks of cancer if you follow the link I posted. Targeting aneuploid cancer cells would be difficult because all cells have chromosomes and some cells different numbers of chromosomes, such as germ cells (which are haploid) or multinucleated cells (e.g. some muscle cells). I can imagine that a therapy that tried to take advantage of this concept would probably be a fusion protein (like the linked paper, but for cancer) of some intracellular sensor of genomic stability (some DNA damage protein or something involved in chromosomal sorting) and something that kills/sensitizes the cell to treatment (caspase domain/toxin/sodium-iodide symporter) packaged into a viral vector.

    http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0022572 [plos.org]

    - Joe

    • (Score: 0) by Anonymous Coward on Friday June 05 2015, @01:45AM

      by Anonymous Coward on Friday June 05 2015, @01:45AM (#192336)

      If there is a commonality in all cases I would say its a single disease. And right, actually targeting something like aneuploidy is not straight forward. However, I'd think the off target effects on normally 'chromosomally special' cells would be no worse than current treatments.